# OnCo record spc (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/spc/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "spc" ;
  schema:name "Supplementary protection certificate (EU)"@en ;
  schema:alternateName "supplementary protection certificate"@en, "supplementary protection certificates"@en, "SPC"@en, "SPCs"@en, "Regulation 469/2009"@en, "SPC manufacturing waiver"@en, "SPC waiver"@en, "paediatric extension"@en, "patent term extension"@en ;
  schema:description "The EU's version of patent term restoration: up to five extra years of protection for a medicine to make up for the years spent in trials and review, so that a cancer drug gets about fifteen years of protected sales after approval, plus six months for paediatric studies."@en ;
  schema:url <https://onco.cc/terms/spc/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Supplementary_protection_certificate> ;
  schema:citation <https://en.wikipedia.org/wiki/Supplementary_protection_certificate>, <https://eur-lex.europa.eu/eli/reg/2009/469/oj>, <https://eur-lex.europa.eu/eli/reg/2019/933/oj> ;
  onco:tag "law", "eu" ;
  onco:related <https://onco.cc/terms/eu-data-exclusivity/>, <https://onco.cc/terms/hatch-waxman/>, <https://onco.cc/terms/us-regulatory-exclusivity/>, <https://onco.cc/terms/eu-paediatric-regulation/>, <https://onco.cc/terms/biosimilar/>, <https://onco.cc/terms/eu-pharma-package/>, <https://onco.cc/terms/trips-doha/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-drug-pricing/> .
